Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

A Smart Mobile Health Tool Versus a Paper Action Plan to Support Self-Management of Chronic Obstructive Pulmonary Disease Exacerbations: Randomized Controlled Trial.

Boer L, Bischoff E, van der Heijden M, Lucas P, Akkermans R, Vercoulen J, Heijdra Y, Assendelft W, Schermer T.

JMIR Mhealth Uhealth. 2019 Oct 9;7(10):e14408. doi: 10.2196/14408.

2.

The Relationship Between Real-World Inhaled Corticosteroid Adherence and Asthma Outcomes: A Multilevel Approach.

Vervloet M, van Dijk L, Spreeuwenberg P, Price D, Chisholm A, Van Ganse E, Pinnock H, Rand CS, Eakin MN, Schermer T, Souverein PC, Dima AL; Respiratory Effectiveness Group's Adherence Working Group.

J Allergy Clin Immunol Pract. 2019 Sep 18. pii: S2213-2198(19)30780-9. doi: 10.1016/j.jaip.2019.09.003. [Epub ahead of print]

PMID:
31541763
3.

Effects of the Spirometry Learning Module on the knowledge, confidence, and experience of spirometry operators.

Parsons R, Schembri D, Hancock K, Lonergan A, Barton C, Schermer T, Crockett A, Frith P, Effing T.

NPJ Prim Care Respir Med. 2019 Aug 9;29(1):30. doi: 10.1038/s41533-019-0143-9.

4.

Implementation of web-based hospital specialist consultations to improve quality and expediency of general practitioners' care: a feasibility study.

van der Velden T, Schalk BWM, Harmsen M, Adriaansens G, Schermer TR, Ten Dam MA.

BMC Fam Pract. 2019 May 29;20(1):73. doi: 10.1186/s12875-019-0960-5.

5.

Age- and sex-specific prevalence of chronic comorbidity in adult patients with asthma: A real-life study.

Veenendaal M, Westerik JAM, van den Bemt L, Kocks JWH, Bischoff EW, Schermer TR.

NPJ Prim Care Respir Med. 2019 Apr 29;29(1):14. doi: 10.1038/s41533-019-0127-9.

6.

Patient Characteristics and General Practitioners' Advice to Stop Statins in Oldest-Old Patients: a Survey Study Across 30 Countries.

van der Ploeg MA, Streit S, Achterberg WP, Beers E, Bohnen AM, Burman RA, Collins C, Franco FG, Gerasimovska-Kitanovska B, Gintere S, Gomez Bravo R, Hoffmann K, Iftode C, Peštić SK, Koskela TH, Kurpas D, Maisonneuve H, Mallen CD, Merlo C, Mueller Y, Muth C, Petrazzuoli F, Rodondi N, Rosemann T, Sattler M, Schermer T, Šter MP, Švadlenková Z, Tatsioni A, Thulesius H, Tkachenko V, Torzsa P, Tsopra R, Tuz C, Vaes B, Viegas RPA, Vinker S, Wallis KA, Zeller A, Gussekloo J, Poortvliet RKE.

J Gen Intern Med. 2019 Sep;34(9):1751-1757. doi: 10.1007/s11606-018-4795-x. Epub 2019 Jan 16.

7.

Validation of ACCESS: an automated tool to support self-management of COPD exacerbations.

Boer LM, van der Heijden M, van Kuijk NM, Lucas PJ, Vercoulen JH, Assendelft WJ, Bischoff EW, Schermer TR.

Int J Chron Obstruct Pulmon Dis. 2018 Oct 10;13:3255-3267. doi: 10.2147/COPD.S167272. eCollection 2018.

8.

Primary care cohort study in the sequence of diagnosing chronic respiratory diseases and prescribing inhaled corticosteroids.

Geraets I, Schermer T, Kocks JWH, Akkermans R, Bischoff E, van den Bemt L.

NPJ Prim Care Respir Med. 2018 Oct 9;28(1):37. doi: 10.1038/s41533-018-0106-6.

9.

Development and Validation of Personalized Prediction to Estimate Future Risk of Severe Exacerbations and Uncontrolled Asthma in Patients with Asthma, Using Clinical Parameters and Early Treatment Response.

Boer S, Sont JK, Loijmans RJB, Snoeck-Stroband JB, Ter Riet G, Schermer TRJ, Assendelft WJJ, Honkoop PJ.

J Allergy Clin Immunol Pract. 2019 Jan;7(1):175-182.e5. doi: 10.1016/j.jaip.2018.06.007. Epub 2018 Jun 21.

PMID:
29936188
10.

Point of care microspirometry to facilitate the COPD diagnostic process in primary care: a clustered randomised trial.

Schermer TR, Vatsolaki M, Behr R, Grootens J, Cretier R, Akkermans R, Denis J, Poels P, van den Bemt L.

NPJ Prim Care Respir Med. 2018 May 22;28(1):17. doi: 10.1038/s41533-018-0083-9.

11.

Is the plasma aldosterone-to-renin ratio associated with blood pressure response to treatment in general practice?

Käyser SC, Schalk BWM, de Grauw WJC, Schermer TR, Akkermans RP, Lenders JWM, Deinum J, Biermans MCJ.

Fam Pract. 2019 Mar 20;36(2):154-161. doi: 10.1093/fampra/cmy039.

PMID:
29788258
12.

'Exacerbation-free time' to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): a prospective observational study.

Boer LM, Bischoff EW, Borgijink X, Vercoulen JH, Akkermans RP, Kerstjens HAM, Assendelft WJ, Schermer TR.

NPJ Prim Care Respir Med. 2018 Apr 3;28(1):12. doi: 10.1038/s41533-018-0079-5.

13.

Exacerbations in Adults with Asthma: A Systematic Review and External Validation of Prediction Models.

Loymans RJB, Debray TPA, Honkoop PJ, Termeer EH, Snoeck-Stroband JB, Schermer TRJ, Assendelft WJJ, Timp M, Chung KF, Sousa AR, Sont JK, Sterk PJ, Reddel HK, Ter Riet G.

J Allergy Clin Immunol Pract. 2018 Nov - Dec;6(6):1942-1952.e15. doi: 10.1016/j.jaip.2018.02.004. Epub 2018 Feb 15.

14.

Prevalence of primary aldosteronism in primary care: a cross-sectional study.

Käyser SC, Deinum J, de Grauw WJ, Schalk BW, Bor HJ, Lenders JW, Schermer TR, Biermans MC.

Br J Gen Pract. 2018 Feb;68(667):e114-e122. doi: 10.3399/bjgp18X694589. Epub 2018 Jan 15.

15.

Longitudinal outcomes of different asthma phenotypes in primary care, an observational study.

Khusial RJ, Sont JK, Loijmans RJB, Snoeck-Stroband JB, Assendelft PJJ, Schermer TRJ, Honkoop PJ; ACCURATE Study Group.

NPJ Prim Care Respir Med. 2017 Oct 3;27(1):55. doi: 10.1038/s41533-017-0057-3.

16.

The Global Lung Function Initiative 2012 Equations Are as Well-Suited as Local Population Derived Equations to a Sample of Healthy Professional Firefighters.

Slattery F, Schermer T, Esterman A, Johnston K, Crockett A.

Can Respir J. 2017;2017:6327180. doi: 10.1155/2017/6327180. Epub 2017 May 25.

17.

Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD.

Westerik JA, Metting EI, van Boven JF, Tiersma W, Kocks JW, Schermer TR.

Respir Res. 2017 Feb 6;18(1):31. doi: 10.1186/s12931-017-0512-2.

18.

Should the diagnosis of COPD be based on a single spirometry test?

Schermer TR, Robberts B, Crockett AJ, Thoonen BP, Lucas A, Grootens J, Smeele IJ, Thamrin C, Reddel HK.

NPJ Prim Care Respir Med. 2016 Sep 29;26:16059. doi: 10.1038/npjpcrm.2016.59.

19.

PELICAN: Content evaluation of patient-centered care for children with asthma based on an online tool.

van Bragt S, van den Bemt L, Cretier R, van Weel C, Merkus P, Schermer T.

Pediatr Pulmonol. 2016 Oct;51(10):993-1003. doi: 10.1002/ppul.23397. Epub 2016 Apr 29.

PMID:
27128738
20.

Identifying patients at risk for severe exacerbations of asthma: development and external validation of a multivariable prediction model.

Loymans RJ, Honkoop PJ, Termeer EH, Snoeck-Stroband JB, Assendelft WJ, Schermer TR, Chung KF, Sousa AR, Sterk PJ, Reddel HK, Sont JK, Ter Riet G.

Thorax. 2016 Sep;71(9):838-46. doi: 10.1136/thoraxjnl-2015-208138. Epub 2016 Apr 4. Erratum in: Thorax. 2018 Aug;73(8):795-796. Corrected abstract.

PMID:
27044486
21.

How GPs value guidelines applied to patients with multimorbidity: a qualitative study.

Luijks H, Lucassen P, van Weel C, Loeffen M, Lagro-Janssen A, Schermer T.

BMJ Open. 2015 Oct 26;5(10):e007905. doi: 10.1136/bmjopen-2015-007905.

22.

The Effect of Comorbidity on Glycemic Control and Systolic Blood Pressure in Type 2 Diabetes: A Cohort Study with 5 Year Follow-Up in Primary Care.

Luijks H, Biermans M, Bor H, van Weel C, Lagro-Janssen T, de Grauw W, Schermer T.

PLoS One. 2015 Oct 1;10(10):e0138662. doi: 10.1371/journal.pone.0138662. eCollection 2015.

23.

Rhinosinusitis in morbidity registrations in Dutch General Practice: a retro-spective case-control study.

Hoffmans R, Schermer T, van der Linde K, Bor H, van Boven K, van Weel C, Fokkens W.

BMC Fam Pract. 2015 Sep 11;16:120. doi: 10.1186/s12875-015-0332-8.

24.

Are asthma patients at increased risk of clinical depression? A longitudinal cohort study.

van den Bemt L, Luijks H, Bor H, Termeer E, Lucassen P, Schermer T.

J Asthma. 2016;53(1):43-9. doi: 10.3109/02770903.2015.1059852. Epub 2015 Aug 24.

PMID:
26313241
25.

Exploring the impact of chronic obstructive pulmonary disease (COPD) on diabetes control in diabetes patients: a prospective observational study in general practice.

Luijks HD, de Grauw WJ, Bor JH, van Weel C, Lagro-Janssen AL, Biermans MC, Schermer TR.

NPJ Prim Care Respir Med. 2015 Apr 23;25:15032. doi: 10.1038/npjpcrm.2015.32.

26.

Prevalence of inappropriate prescribing of inhaled corticosteroids for respiratory tract infections in the Netherlands: a retrospective cohort study.

Teichert M, Schermer T, van den Nieuwenhof L, De Smet PA, Wensing M.

NPJ Prim Care Respir Med. 2014 Oct 16;24:14086. doi: 10.1038/npjpcrm.2014.86.

27.

Symptom- and fraction of exhaled nitric oxide-driven strategies for asthma control: A cluster-randomized trial in primary care.

Honkoop PJ, Loijmans RJ, Termeer EH, Snoeck-Stroband JB, van den Hout WB, Bakker MJ, Assendelft WJ, ter Riet G, Sterk PJ, Schermer TR, Sont JK; Asthma Control Cost-Utility Randomized Trial Evaluation (ACCURATE) Study Group.

J Allergy Clin Immunol. 2015 Mar;135(3):682-8.e11. doi: 10.1016/j.jaci.2014.07.016. Epub 2014 Aug 28.

PMID:
25174865
28.

PELICAN: a cluster-randomized controlled trial in Dutch general practices to assess a self-management support intervention based on individual goals for children with asthma.

van Bragt S, van den Bemt L, Kievits R, Merkus P, van Weel C, Schermer T.

J Asthma. 2015 Mar;52(2):211-9. doi: 10.3109/02770903.2014.952439. Epub 2014 Aug 28.

PMID:
25166455
29.

Diagnostic accuracy of pre-bronchodilator FEV1/FEV6 from microspirometry to detect airflow obstruction in primary care: a randomised cross-sectional study.

van den Bemt L, Wouters BC, Grootens J, Denis J, Poels PJ, Schermer TR.

NPJ Prim Care Respir Med. 2014 Aug 14;24:14033. doi: 10.1038/npjpcrm.2014.33.

30.

Chronic respiratory conditions in a cohort of metropolitan fire-fighters: associations with occupational exposure and quality of life.

Schermer TR, Malbon W, Morgan M, Smith M, Crockett AJ.

Int Arch Occup Environ Health. 2014 Nov;87(8):919-28. doi: 10.1007/s00420-014-0935-8. Epub 2014 Feb 26.

PMID:
24570328
31.

Impact of switching to new spirometric reference equations on severity staging of airflow obstruction in COPD: a crosssectional observational study in primary care.

Sluga R, Smeele IJ, Lucas AE, Thoonen BP, Grootens-Stekelenburg JG, Heijdra YF, Schermer TR.

Prim Care Respir J. 2014 Mar;23(1):85-91. doi: 10.4104/pcrj.2014.00006.

32.

Predicting an accelerated lung function decline in smokers: is there a proper threshold?

Akkermans RP, Biermans M, Robberts B, ter Riet G, Jacobs A, van Weel C, Wensing M, Schermer T.

Eur Respir J. 2014 Jan;43(1):308-9. doi: 10.1183/09031936.00102013. No abstract available.

33.

Validity, reliability and discriminative capacity of an electronic quality of life instrument (Pelican) for childhood asthma in the Netherlands.

van Bragt S, van den Bemt L, Thoonen B, Jacobs J, Merkus P, Schermer T.

Qual Life Res. 2014 Apr;23(3):927-38. doi: 10.1007/s11136-013-0533-3. Epub 2013 Oct 1.

PMID:
24081870
34.

Tissue-engineered fibrin-based heart valve with a tubular leaflet design.

Weber M, Heta E, Moreira R, Gesche VN, Schermer T, Frese J, Jockenhoevel S, Mela P.

Tissue Eng Part C Methods. 2014 Apr;20(4):265-75. doi: 10.1089/ten.TEC.2013.0258. Epub 2013 Oct 19.

35.

Change in lung function over time in male metropolitan firefighters and general population controls: a 3-year follow-up study.

Schermer TR, Malbon W, Adams R, Morgan M, Smith M, Crockett AJ.

J Occup Health. 2013;55(4):267-75. Epub 2013 Jun 24.

36.

Comparison between an online self-administered and an interviewer-administered version of the Asthma Control Questionnaire: a cross-sectional validation study.

Honkoop PJ, Loijmans RJ, Termeer EH, Snoeck-Stroband JB, Ter Riet G, Schermer TR, Sont JK; ACCURATE Study Group.

Prim Care Respir J. 2013 Sep;22(3):284-9. doi: 10.4104/pcrj.2013.00041.

37.

COPD prognosis in relation to diagnostic criteria for airflow obstruction in smokers.

Akkermans RP, Biermans M, Robberts B, ter Riet G, Jacobs A, van Weel C, Wensing M, Schermer T.

Eur Respir J. 2014 Jan;43(1):54-63. doi: 10.1183/09031936.00158212. Epub 2013 Apr 5.

38.

The acute effect of cigarette smoking on the high-sensitivity CRP and fibrinogen biomarkers in chronic obstructive pulmonary disease patients.

van Dijk WD, Akkermans R, Heijdra Y, Weel Cv, Schermer TR, Scheepers PT, Lenders JW.

Biomark Med. 2013 Apr;7(2):211-9. doi: 10.2217/bmm.12.112.

PMID:
23547816
39.

Using the DOSE index to predict changes in health status of patients with COPD: a prospective cohort study.

Rolink M, van Dijk W, van den Haak-Rongen S, Pieters W, Schermer T, van den Bemt L.

Prim Care Respir J. 2013 Jun;22(2):169-74. doi: 10.4104/pcrj.2013.00033.

40.

An autonomous mobile system for the management of COPD.

van der Heijden M, Lucas PJ, Lijnse B, Heijdra YF, Schermer TR.

J Biomed Inform. 2013 Jun;46(3):458-69. doi: 10.1016/j.jbi.2013.03.003. Epub 2013 Mar 15.

41.

Don't pay for poor quality spirometry tests.

Enright P, Schermer T.

Prim Care Respir J. 2013 Mar;22(1):15-6. doi: 10.4104/pcrj.2013.00023. No abstract available.

42.

Short-acting anticholinergic bronchodilation does not increase cardiovascular events in smokers with mild to moderate pulmonary obstruction.

de Jong E, van Dijk WD, Heijdra Y, Lenders JW, van Weel C, Akkermans R, Schermer TR.

Respirology. 2013 May;18(4):663-8. doi: 10.1111/resp.12040.

PMID:
23278997
43.

Comprehensive self management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: randomised controlled trial.

Bischoff EW, Akkermans R, Bourbeau J, van Weel C, Vercoulen JH, Schermer TR.

BMJ. 2012 Nov 28;345:e7642. doi: 10.1136/bmj.e7642.

44.

Prevalence and incidence density rates of chronic comorbidity in type 2 diabetes patients: an exploratory cohort study.

Luijks H, Schermer T, Bor H, van Weel C, Lagro-Janssen T, Biermans M, de Grauw W.

BMC Med. 2012 Oct 29;10:128. doi: 10.1186/1741-7015-10-128.

45.

Cigarette smoke retention and bronchodilation in patients with COPD. A controlled randomized trial.

van Dijk WD, Heijdra Y, Lenders JW, Klerx W, Akkermans R, van der Pouw A, van Weel C, Scheepers PT, Schermer TR.

Respir Med. 2013 Jan;107(1):112-9. doi: 10.1016/j.rmed.2012.09.019. Epub 2012 Oct 12.

46.

Diagnostic pathways for interstitial lung diseases in primary care.

Heins MJ, Schermer TR, de Saegher ME, van Boven K, van Weel C, Grutters JC.

Prim Care Respir J. 2012 Sep;21(3):253-4. doi: 10.4104/pcrj.2012.00074. No abstract available.

47.

PELICAN: A quality of life instrument for childhood asthma: study protocol of two randomized controlled trials in primary and specialized care in the Netherlands.

van Bragt S, van den Bemt L, Thoonen B, van Weel C, Merkus P, Schermer T.

BMC Pediatr. 2012 Aug 30;12:137. doi: 10.1186/1471-2431-12-137.

48.

GPs' considerations in multimorbidity management: a qualitative study.

Luijks HD, Loeffen MJ, Lagro-Janssen AL, van Weel C, Lucassen PL, Schermer TR.

Br J Gen Pract. 2012 Jul;62(600):e503-10. doi: 10.3399/bjgp12X652373.

49.

Primary care research--an international responsibility.

Hay AD, Rortveit G, Purdy S, Adams J, Sanci LA, Schermer TR, Schers HJ, van der Windt DA.

Fam Pract. 2012 Oct;29(5):499-500. Epub 2012 Apr 20. No abstract available.

PMID:
22523391
50.

How do dyspnoea scales compare with measurement of functional capacity in patients with COPD and at risk of COPD?

Boer LM, Asijee GM, van Schayck OC, Schermer TR.

Prim Care Respir J. 2012 Jun;21(2):202-7. doi: 10.4104/pcrj.2012.00031.

Supplemental Content

Loading ...
Support Center